XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT03745053

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03745053
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03745053. Randomized; single masking; primary purpose treatment. Start 2019-02-05 (actual); primary completion 2023-09-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
Acronym
XLIMIT
Intervention (Device)
Xlimus DES Implantation during coronary angioplasty
Intervention (Device)
Synergy DES Implantation during coronary angioplasty
Lead sponsor
Cardionovum GmbH (class: industry)
Collaborator
Mediolanum Cardio Research (class: other)

Record details

Record id
cardio:ct-nct03745053
Content hash
7753bf7084c717af11ec83ff4eed4385b7651e61a5046e50406c706539345224